The draft local coverage determination finalized by Medicare contractor Palmetto GBA for Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs), released on October 26 and effective December 10, is responsive to some concerns raised by the Infectious Diseases Society of America but leaves other issues unaddressed.
As health care shifts from reimbursement based on numbers of patients seen or procedures performed to reimbursement based on quality of care, the infectious diseases (ID) specialty will need to develop measures that accurately reflect the complex, expert care that ID physicians provide.
Leading infectious disease experts will highlight issues critical to confronting, controlling and reversing the growing global public health threat of pathogens that are increasingly unresponsive to existing treatments, as the World Antimicrobial Resistance Congress opens today in Washington, DC.
At a time when needs for infectious disease and HIV researchers to combat antimicrobial resistance, global outbreaks, and biosecurity threats and advance a cure for HIV, are growing, the low baseline funding for career development grants announced by the National Institutes of Allergy and Infectious Diseases (NIAID) this week for the coming year will challenge efforts to bring new physician scientists to the field.
The administration’s reported intention to redefine gender based entirely on sex at birth disregards not only current biologic science but also established, prevailing medical and legal standards, while re-enforcing stigma and discrimination against transgender people.
Delineating the broad range of public health contributions provided by physicians specializing in infectious diseases, an article published today in Clinical Infectious Diseases sets forth concrete recommendations to ensure continued training and practice in the field meet increasing demand.
Tracking rates of childhood vaccination across the United States, data released by the Centers for Disease Control and Prevention Friday shows concerning trends, persisting gaps, and missed opportunities to use one of the greatest tools modern medicine offers to prevent disease and protect public health.
The Department of Health and Human Services declaration that the impending landfall of Hurricane Michael on Florida’s panhandle poses a public health emergency is one of a series of steps that will be critical to addressing the medical needs and infectious disease impacts that accompany catastrophic storms and their aftermaths.
Therapy dogs help ease stress in young patients with cancer, but can spread methicillin-resistant Staphylococcus aureus (MRSA), putting vulnerable kids at risk for a serious infection. Cleaning the dogs with special antibacterial shampoo and wipes reduces MRSA carriage and helps keep the kids safe, suggests a first-of-its-kind study presented at IDWeek 2018.
Clinicians prescribed antibiotics without an infection-related diagnosis nearly half of the time and one in five prescriptions were provided without an in-person visit, according to research being presented at IDWeek 2018. The study, which is the first to look at overall outpatient antibiotic prescribing, analyzed more than half a million prescriptions from 514 outpatient clinics.
Teens and young adults who have injected drugs are at risk for contracting hepatitis C, but most aren’t tested and therefore don’t receive life-saving treatment, according to a national study being presented at IDWeek 2018. The study of more than 250,000 at-risk youth found only one-third of those with diagnosed opioid use disorder (OUD) were tested for hepatitis C.
Antiretroviral therapy (ART) is a vital treatment that helps prevent a pregnant woman from passing HIV to her baby, but one type of ART medication may increase the risk the child will develop a neurological condition, according to new research being presented at IDWeek 2018.